EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Genetic and Transcriptomic Profiles Identify Potential Therapeutic Targets of Concurrent Follicular and Diffuse Large B‐Cell Lymphoma and Transformed Follicular Lymphoma

Rui Sun, Rui-Chi Li, Hui-Ying Li, Nan Wang, Tian-Yuan Xu, Shuang Tian, Di Fu, Chen Li, Fang-Yi Zhang, Yan Feng, Shu Cheng, Peng-Peng Xu und 3 weitere

Hematological Oncology · 2026-03 · 44 (2)

DOI: 10.1002/hon.70188 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hematological Oncology, online erschienen am 19.03.2026. Verfasst von Rui Sun und 14 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin H…. Hauptthemen laut MEDLINE: Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Transcriptome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Chang Jiang Scholars Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Concurrent follicular and diffuse large B‐cell lymphoma (FL/DLBCL) and transformed follicular lymphoma (tFL) are distinct B‐cell lymphoma entities, posing challenges for understanding pathogenesis and clinical management. The clinical characteristics of 98 FL/DLBCL, 31 tFL, 403 FL1‐2/3A, and 608 DLBCL patients were analyzed. DNA sequencing was performed in these cohorts, and RNA sequencing was performed on 60 FL/DLBCL, 8 tFL, 175 FL1‐2/3A, and 329 DLBCL patients. FL/DLBCL was characterized by localized disease, whereas tFL was associated with elevated LDH levels. Genomic analyses revealed that FL/DLBCL harbored frequent mutations in the Wnt signaling pathway but lacked the epigenetic alterations observed in FL, while tFL retained FL‐associated epigenetic mutations and acquired additional alterations in cell cycle/p53 and JAK‐STAT pathways. Both FL/DLBCL and tFL exhibited increased gene mutations related to the tumor microenvironment and B‐cell differentiation, most notably CD70 and CD79B. Transcriptomic profiling further demonstrated enrichment of tumor microenvironment and B‐cell differentiation‐related pathways, consistent with the mutational landscape. Functionally, co‐culture assays showed that knockdown of CD70 in B‐lymphoma cells reduced naive CD4+ and CD8+ T‐cell subsets, whereas CD79B Y197H transfected B‐lymphoma cells enhanced tumor cell viability. Our findings comprehensively characterize FL/DLBCL and tFL molecularly, elucidating their distinct pathogenesis and rationalize CD70 and CD79B targeted immunotherapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, FollicularLymphoma, Large B-Cell, DiffuseTranscriptomeHumansGene Expression ProfilingMutationTumor MicroenvironmentGene Expression Regulation, NeoplasticFemale

Stichwörter der Autor:innen

B‐cell differentiationconcurrentdiffuse large B‐cell lymphomafollicular lymphomatransformedtumor microenvironment

Autor:innen und Institutionen

  • Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine…
  • Network and Information Center, Shanghai Jiao Tong University, Shanghai, China.
  • State Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
  • Pôle de Recherches Sino-Français en Science du Vivant et Génomique, Laboratory of Molecular Pathology, Shanghai, China.

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Chang Jiang Scholars Program
  • Shanghai Clinical Research Center for Cell Therapy
  • Clinical Research Plan of Shanghai Hospital Development Center
  • Multicenter Hematology-Oncology Programs Evaluation System
  • Collaborative Innovation Center of Systems Biomedicine
  • STCSM Shanghai Natural Science Grants

Zitieren

APA

Sun, R., Li, R. C., Li, H. Y., Wang, N., Xu, T. Y., Tian, S., Fu, D., Li, C., Zhang, F. Y., Feng, Y., Cheng, S., Xu, P. P., Wang, L., Zheng, Z., & Zhao, W. L. (2026). Genetic and Transcriptomic Profiles Identify Potential Therapeutic Targets of Concurrent Follicular and Diffuse Large B‐Cell Lymphoma and Transformed Follicular Lymphoma. Hematological Oncology, 44(2). https://doi.org/10.1002/hon.70188

Vancouver

Sun R, Li RC, Li HY, Wang N, Xu TY, Tian S, et al. Genetic and Transcriptomic Profiles Identify Potential Therapeutic Targets of Concurrent Follicular and Diffuse Large B‐Cell Lymphoma and Transformed Follicular Lymphoma. Hematological Oncology. 2026;44(2). doi:10.1002/hon.70188

BibTeX
@article{Sun2026,
  author = {Sun, Rui and Li, Rui-Chi and Li, Hui-Ying and Wang, Nan and Xu, Tian-Yuan and Tian, Shuang and Fu, Di and Li, Chen and Zhang, Fang-Yi and Feng, Yan and Cheng, Shu and Xu, Peng-Peng and Wang, Li and Zheng, Zhong and Zhao, Wei-Li},
  title = {Genetic and Transcriptomic Profiles Identify Potential Therapeutic Targets of Concurrent Follicular and Diffuse Large B‐Cell Lymphoma and Transformed Follicular Lymphoma},
  journal = {Hematological Oncology},
  year = {2026},
  volume = {44},
  number = {2},
  doi = {10.1002/hon.70188}
}
Kostenlos starten →